Clinical Trial Update: Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures [Phase 2]

View source ↗

Summary

Phase 2 controlled study evaluating growth hormone for tibia fractures has completed. The trial assessed efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fracture
• Tibia Fracture

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Bone Fracture, Tibia Fractures | Phase 2 | Status: COMPLETED